# Sierra Leone Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Sierra Leone HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Sierra Leone (SLE)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $3.6M
- Products: 13
- Buyer markets: 21
- Average CAGR: +17.9%
- Global sector size: $188.6B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $127.9B | $2.1M | $38.1B | -2.6% | 15 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $16.1B | $60.6K | $9.5B | -11.6% | 6 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $6.3B | $12.4K | $7.6B | -15.2% | 4 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $11.5B | $52.8K | $4.5B | +32.5% | 3 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $11.2B | $121.7K | $4.4B | +16.9% | 5 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $6.2B | $30.8K | $2.8B | +21.9% | 1 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $2.4B | $834.9K | $2.4B | +376.5% | 2 | +0.0% |
| HS 381800 - Chemical elements: doped for use in electronics, in the form of discs, wafers or similar forms: chemical compounds doped for use in electronics | $3.0B | $871.1 | $2.0B | +52.4% | 1 | +0.0% |
| HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $521.9M | $1.4K | $964.2M | -24.9% | 1 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $1.8B | $242.3 | $889.0M | -25.0% | 1 | +0.0% |
| HS 281820 - Aluminium oxide: other than artificial corundum | $656.5M | $36.5K | $716.4M | +21.1% | 1 | +0.0% |
| HS 294110 - Antibiotics: penicillins and their derivatives with a penicillanic acid structure: salts thereof | $485.4M | $360.4K | $507.7M | +28.7% | 1 | +0.2% |
| HS 381519 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with an active substance other than nickel or precious metals or their compounds, n.e.c. or included | $634.0M | $0.1 | $448.7M | -89.0% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $17.0B calculated opportunity across 5 products.
- Germany (DEU): $8.8B calculated opportunity across 5 products.
- Belgium (BEL): $7.9B calculated opportunity across 2 products.
- Canada (CAN): $6.9B calculated opportunity across 4 products.
- Italy (ITA): $4.9B calculated opportunity across 1 products.
- United Kingdom (GBR): $4.6B calculated opportunity across 2 products.
- France (FRA): $4.1B calculated opportunity across 2 products.
- Poland (POL): $3.7B calculated opportunity across 4 products.
- Ireland (IRL): $3.2B calculated opportunity across 1 products.
- Spain (ESP): $2.1B calculated opportunity across 3 products.
- Taiwan (TWN): $2.0B calculated opportunity across 1 products.
- South Africa (ZAF): $1.9B calculated opportunity across 3 products.

## Growth stars

- HS 382319: +376.5% average CAGR, $2.4B calculated opportunity.
- HS 381800: +52.4% average CAGR, $2.0B calculated opportunity.
- HS 382200: +32.5% average CAGR, $4.5B calculated opportunity.
- HS 294110: +28.7% average CAGR, $507.7M calculated opportunity.
- HS 293499: +21.9% average CAGR, $2.8B calculated opportunity.
- HS 281820: +21.1% average CAGR, $716.4M calculated opportunity.
- HS 330499: +16.9% average CAGR, $4.4B calculated opportunity.
- HS 300490: -2.6% average CAGR, $38.1B calculated opportunity.
- HS 382499: -11.6% average CAGR, $9.5B calculated opportunity.
- HS 330210: -15.2% average CAGR, $7.6B calculated opportunity.

## Diversification opportunities

- HS 300490: 15 buyer markets, $38.1B calculated opportunity.
- HS 382499: 6 buyer markets, $9.5B calculated opportunity.
- HS 330499: 5 buyer markets, $4.4B calculated opportunity.
- HS 330210: 4 buyer markets, $7.6B calculated opportunity.
- HS 382200: 3 buyer markets, $4.5B calculated opportunity.
- HS 382319: 2 buyer markets, $2.4B calculated opportunity.
- HS 293499: 1 buyer markets, $2.8B calculated opportunity.
- HS 381800: 1 buyer markets, $2.0B calculated opportunity.
- HS 382600: 1 buyer markets, $964.2M calculated opportunity.
- HS 300212: 1 buyer markets, $889.0M calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.